Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase

Biochemistry. 2000 Aug 8;39(31):9201-12. doi: 10.1021/bi0009441.

Abstract

The physicochemical properties of recombinant wild type and three site-directed mutants of apolipoprotein C-III (apoC-III), designed by molecular modeling to alter specific amino acid residues implicated in lipid binding (L9T/T20L, F64A/W65A) or LPL inhibition (K21A), were compared. Relative lipid binding efficiencies to dimyristoylphosphatidylcholine (DMPC) were L9T/T20L > WT >K21A > F64A/W65A with an inverse correlation with size of the discoidal complexes formed. Physicochemical analysis (Trp fluorescence, circular dichroism, and GdnHCl denaturation) suggests that L9T/T20L forms tighter and more stable lipid complexes with phospholipids, while F64A/W65A associates less tightly. Lipid displacement properties were tested by gel-filtrating apoE:dipalmitoylphosphatidylcholine (DPPC) discoidal complexes mixed with the various apoC-III variants. All apoC-III proteins bound to the apoE:DPPC complexes; the amount of apoE displaced from the complex was dependent on the apoC-III lipid binding affinity. All apoC-III proteins inhibited LPL in the presence or absence of apoC-II, with F64A/W65A displaying the most inhibition, suggesting that apoC-III inhibition of LPL is independent of lipid binding and therefore of apoC-II displacement. Taken together. these data suggest that the hydrophobic residues F64 and W65 are crucial for the lipid binding properties of apoC-III and that redistribution of the N-terminal helix of apoC-III (L9T/T20L) enhances the stability of the lipid-bound protein, while LPL inhibition by apoC-III is likely to be due to protein:protein interactions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1,2-Dipalmitoylphosphatidylcholine / chemistry
  • Amino Acid Sequence
  • Animals
  • Apolipoprotein C-III
  • Apolipoproteins C / chemistry*
  • Apolipoproteins C / genetics*
  • Apolipoproteins C / isolation & purification
  • Apolipoproteins C / metabolism
  • Apolipoproteins E / metabolism*
  • Binding Sites / genetics
  • Cattle
  • Chemical Phenomena
  • Chemistry, Physical
  • Chromatography, Gel
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / isolation & purification
  • Enzyme Inhibitors / metabolism
  • Genetic Variation
  • Genetic Vectors / chemical synthesis
  • Humans
  • Lipid Metabolism*
  • Lipoprotein Lipase / antagonists & inhibitors*
  • Models, Molecular
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed*
  • Protein Structure, Secondary / genetics
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / chemistry*
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / metabolism
  • Structure-Activity Relationship

Substances

  • Apolipoprotein C-III
  • Apolipoproteins C
  • Apolipoproteins E
  • Enzyme Inhibitors
  • Recombinant Proteins
  • 1,2-Dipalmitoylphosphatidylcholine
  • Lipoprotein Lipase